Cerus Corporation ( CERS) - Key Metrics
CERS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.30 | -$0.01 | $0.07 | $0.06 |
| 2025Q3 | $0.27 | $0 | $0.01 | $0 |
| 2025Q2 | $0.27 | -$0.03 | -$0.01 | -$0.02 |
| 2025Q1 | $0.23 | -$0.04 | $0 | -$0.01 |
CERS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -44.94 |
| 2025Q3 | ? | -4013.29 |
| 2025Q2 | ? | -11.82 |
| 2025Q1 | ? | -8.42 |
CERS Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -0.93% | ? |
| 2025Q4 | 1.24% | ? |
| 2025Q3 | 0.03% | ? |
| 2025Q2 | -1.08% | ? |
| 2025Q1 | -0.37% | ? |
CERS
Price: $2.93
52 week price:
Earnings Per Share: -0.05 USD
Exchange: NGM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 1.8 million
Ebitda: -11.8 millionMarket Capitalization: 633.2 million